Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug testing

15-Sep-2017 - MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing. This lab ...

Engineered heart muscle for the treatment of heart failure

License agreement between Georg-August-Universität Göttingen and Repairon GmbH

25-Apr-2017 - MBM ScienceBridge GmbH successfully negotiated a license agreement between Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin (UMG) and the biotech company Repairon GmbH about commercial production and use of engineered human myocardium for heart failure repair. ...

Georg-August-University Göttingen, Universitätsmedizin and MRC Technology collaborate to develop new therapy for neurodegenerative diseases

03-Aug-2015 - Georg-August-University Göttingen (UMG) and MRC Technology (MRCT) have signed an exclusive license agreement for the development of a novel therapy for neurodegenerative diseases based on antibody targeting amyloid beta peptides 4-x. The aim is to develop a therapy for Alzheimer's Disease ...